PER 0.00% 10.0¢ percheron therapeutics limited

robstar is back, page-16

  1. 10,387 Posts.
    lightbulb Created with Sketch. 724
    "The proceeds of the Offer are expected to be sufficient to fund the activities of Antisense to the end of 2011 if $2.4 million is raised. However, additional development costs may arise within this period, and additional funding will be required to complete the development and commercialisation of Antisense's drug candidates beyond this time."
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.